Common Contracts
3 similar Common Stock Subscription Agreement contracts by Panther Biotechnology, Inc.
EX-10.1 3 panther_8k-ex1001.htm FORM OF STOCK SUBSCRIPTION AGREEMENT COMMON STOCK SUBSCRIPTION AGREEMENT PANTHER BIOTECHNOLOGY, INC.Common Stock Subscription Agreement • May 5th, 2020 • Texas
Panther Biotechnology, Inc., a Nevada corporation (the “Company”), is offering for purchase to a limited number of qualified investors up to an aggregate of $750,000.00 (the “Maximum Amount”) in shares of common stock of the Company (the “Shares” or the “Securities”) (the “Offering”) for $0.15 per Share. The Shares are being offered on a “best efforts, no minimum” basis to a limited number of accredited investors and non-“U.S. Persons”. The Offering is made in reliance upon an exemption from registration under the federal securities laws provided by Rule 506(b) of Regulation D and Regulation S of the Securities Act of 1933, as amended. The minimum investment is $25,000.00, although the Company may, in its discretion, accept subscriptions for a lesser amount. The Company reserves the right to reject orders for the purchase of Shares in whole or in part, and if a subscription is rejected the subscriber’s funds will be returned without interest the next business day after rejection. There
COMMON STOCK SUBSCRIPTION AGREEMENTCommon Stock Subscription Agreement • January 27th, 2017 • Panther Biotechnology, Inc. • Services-engineering, accounting, research, management • Texas
Panther Biotechnology, Inc., a Nevada corporation (the “Company”), is offering for purchase to a limited number of qualified investors up to an aggregate of $750,000.00 (the “Maximum Amount”) in shares of common stock of the Company (the “Shares” or the “Securities”) (the “Offering”) for $0.15 per Share. The Shares are being offered on a “best efforts, no minimum” basis to a limited number of accredited investors and non-“U.S. Persons”. The Offering is made in reliance upon an exemption from registration under the federal securities laws provided by Rule 506(b) of Regulation D and Regulation S of the Securities Act of 1933, as amended. The minimum investment is $25,000.00, although the Company may, in its discretion, accept subscriptions for a lesser amount. The Company reserves the right to reject orders for the purchase of Shares in whole or in part, and if a subscription is rejected the subscriber’s funds will be returned without interest the next business day after rejection. There
COMMON STOCK SUBSCRIPTION AGREEMENTCommon Stock Subscription Agreement • November 15th, 2016 • Panther Biotechnology, Inc. • Services-engineering, accounting, research, management • Texas
Panther Biotechnology, Inc., a Nevada corporation (the “Company”), is offering for purchase to a limited number of qualified investors up to an aggregate of $750,000.00 (the “Maximum Amount”) in shares of common stock of the Company (the “Shares” or the “Securities”) (the “Offering”) for $0.15 per Share. The Shares are being offered on a “best efforts, no minimum” basis to a limited number of accredited investors and non-“U.S. Persons”. The Offering is made in reliance upon an exemption from registration under the federal securities laws provided by Rule 506(b) of Regulation D and Regulation S of the Securities Act of 1933, as amended. The minimum investment is $25,000.00, although the Company may, in its discretion, accept subscriptions for a lesser amount. The Company reserves the right to reject orders for the purchase of Shares in whole or in part, and if a subscription is rejected the subscriber’s funds will be returned without interest the next business day after rejection. There
